Pharmstandard

Pharmstandard

Xconomy

Proteon Therapeutics Plans Path Forward for Blood Vessel Drug

Health
$102,000,000 IPO
Xconomy

Jounce Gets $102M As Biotech IPOs Gain Steam in ’17

Stock markets Earnings
$20,000,000 Venture capital (Series C)
Xconomy , FinSMEs

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Funding Health Science
$56,000,000 Venture capital (Series B)
VentureWire

The Daily Startup: Jounce Therapeutics Raises $56M as Immunotherapy Stays Hot

Funding